• Ending Cancer Starts Here - GIVE NOW

    Ending Cancer Starts Here

    Support breakthroughs in cancer treatments and clinical trials that accelerate advances in the fight against cancer. That’s why your support of the 2017 Annual Fund Drive to Save Lives is so important.

  • Patient Care

    Patient Care

    Award-winning physicians, state-of-the-art facilities, and a high commitment to excellence—qualities that make Lombardi stand out above the rest!

    Learn More
  • Research


    We are developing and testing the cancer treatments of tomorrow - targeted therapies that will improve both survival and quality of life.

    Learn More
  • Education


    Educating and training tomorrow's leaders in cancer treatment and research is our mission.

    Learn More
  • Community


    Lombardi is a resource for our community, dedicated to serving the population of the Washington, DC area.

    Learn More

The Lombardi Atrium is now open and valet parking services are available.

Georgetown Lombardi Comprehensive Cancer Center clinicians are dedicated to providing the best professional care, delivered with compassion, for all patients.

Georgetown Lombardi's seeks to prevent, treat, and cure cancers by linking scientific discovery, expert and compassionate patient care, quality education, and partnership with the community; guided by the principle of cura personalis, "care for the whole person. Georgetown Lombardi's research program includes innovative clinical trials like the one that Melanoma Cancer Survivor, Leta Brown, participated in.

Leta Brown of Maryland was only 43 when she was diagnosed with advanced metastatic melanoma in 2013. She sought treatment at MedStar Georgetown University Hospital where she enrolled in a clinical trial of two immunotherapy agents, nivolumab (Opdivo) and ipilimumab (Yervoy) through Georgetown University's Lombardi Comprehensive Cancer Center. Within weeks her cancer began to shrink. Today she is cancer free. Leta's treatment regimen for advanced melanoma is now FDA approved.